Withdrawal of Registration Statement (ammendment) (aw)
June 19 2020 - 1:10PM
Edgar (US Regulatory)
GENEREX
BIOTECHNOLOGY CORPORATION
June
19, 2020
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
DC 20549
RE:
|
Generex
Biotechnology Corporation (the “Company”)
|
|
(Accession No. 0001607062-20-000159)
|
|
Form AW Application for Withdrawal
|
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended, the Company hereby requests the withdrawal of the Company’s Form
S-1/A registration statement (Accession No. 0001607062-20-000159) filed on June 15, 2020 with respect to the Company’s
Series A Preferred Stock.
The
Form S-1/A was incorrectly tagged as an S-1/A filing instead of a Form S-1 filing. A correctly tagged submission was subsequently
filed as a Form S-1 filing. No securities were sold in connection with the offering.
If
you have any questions, please call Jeff Wofford of Carmel, Milazzo & Feil LLP at (646) 876-0618.
Very
Truly Yours,
GENEREX BIOTECHNOLOGY CORPORATION
By:/s/ Anthony Crisci
Name: Anthony Crisci
Title: Chief
Legal Officer & Chief Administrative Officer
Generex Biotechnology (CE) (USOTC:GNBT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Generex Biotechnology (CE) (USOTC:GNBT)
Historical Stock Chart
From Apr 2023 to Apr 2024